Novel blood test could predict chronic lung disease in preterm babies within hours of birth

A blood test can help predict which preterm babies will go onto develop chronic lung disease, allowing for earlier diagnosis and more targeted treatments, according to a new study.

Pfizer, BioNTech deny Arbutus and Genevant’s Covid vaccine patent infringement claims

Pfizer and BioNTech responded to a patent infringement suit filed by Arbutus Biopharma and Genevant, denying the accusation that their Covid-19 vaccine infringed on patents

July 14, 2023

FDA to host adcomm on PD-L1 as a predictive biomarker for checkpoint inhibitors

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 23, 2024

Lactate’s role in driving cancer cachexia uncovered

Study highlights the significant role of lactate in promoting cancer cachexia via activation of the adipose-specific G-protein-coupled receptor 81 (GPR81), suggesting new therapeutic targets for

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.